Form 4: Goosehead Insurance Director Receives Stock Option Grant
Statement of Changes in Beneficial Ownership
Director William Wade, Jr. was granted 13,979 stock options in Goosehead Insurance, Inc. as part of his compensation.
Summary
- Director William Wade, Jr. received a grant of 13,979 stock options for Class A Common Stock.
- The options have an exercise price of $42.46 per share.
- The grant date for these options is May 5, 2026.
- The options are set to expire on May 5, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- The grant results in potential future dilution for existing shareholders upon exercise.
Risks
- Vesting is subject to continued service, creating a dependency on the director's ongoing tenure.
- Market price volatility could impact the value of the options relative to the $42.46 exercise price.
Future Outlook
The options vest in 12 equal quarterly installments over a three-year period, with full acceleration upon a change in control.
Management Comments
- No specific management commentary provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that equity grants to board members are standard practice in the insurance and financial services sector to ensure governance alignment and retention of key leadership.
Comparison to Industry Standards
- The three-year vesting schedule is consistent with standard corporate governance practices for director equity compensation.
- The use of quarterly installments is a common mechanism to encourage long-term board commitment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | William Wade, Jr. appointed Martin Thornthwaite and Mark E. Jones, Jr. as attorneys-in-fact for SEC filings. | 2026-05-05 | Standard administrative procedure to ensure timely compliance with Section 16 reporting requirements. |
Stakeholder Impact
- Shareholders: Minor dilution impact upon future exercise of options.
- Director: Increased equity stake in the company, aligning incentives with performance.
Next Steps
- Vesting of options in quarterly installments starting after the grant date.
- Potential exercise of options by the director after vesting periods are met.
Key Dates
| Date | Description |
|---|---|
| 2026-05-05 | Grant date of stock options and execution of Power of Attorney. |
| 2026-05-07 | Filing date of the Form 4. |
| 2036-05-05 | Expiration date of the granted stock options. |
Keywords
Goosehead Insurance, GSHD, Form 4, Stock Options, Director Compensation, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.